Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier

Glioblastoma (GBM) is the most malignant form of all primary brain tumors, and it is responsible for around 200,000 deaths each year worldwide. The standard therapy for GBM treatment includes surgical resection followed by temozolomide-based chemotherapy and/or radiotherapy. With this treatment, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rohit K., Calderon, Carlos, Vivas-Mejia, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757885/
https://www.ncbi.nlm.nih.gov/pubmed/35047931
http://dx.doi.org/10.3389/fmedt.2021.678593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757885/
https://www.ncbi.nlm.nih.gov/pubmed/35047931
http://dx.doi.org/10.3389/fmedt.2021.678593

Ejemplares similares